PPL vs RLAY · P/E 22, rev $9.04B vs rev $3.4M
PPL Corporation (PPL) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
PPL currently screens at market cap $26.58B and trailing P/E 21.7. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the PPL and RLAY stock pages for the full models.
Not investment advice.